Richard Scott Struthers

President & CEO · Crinetics Pharmaceuticals

Richard Scott Struthers (President & CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $822K of CRNX (21,981 sh across 2 lots, as filed), executed Mar 16. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$822K

shares × price, as filed

Last traded

Mar 16

Filed Mar 18

Median ADV $326.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

CRNX

Crinetics Pharmaceuticals, Inc. CRNX · 0 buys · 4 sells 4 filings

Recent filings

CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $822K
21,981 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $180K
4,000 sh × $45.00
Exec Sep 26 2025
Filed Sep 30 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $563K
16,463 sh × $34.17
Exec Mar 19 2025
Filed Mar 21 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $576K
10,000 sh × $57.57
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET